Skip to content
Draupnir Bio logo

Draupnir Bio Alternatives & Competitors

12 companies similar to Draupnir Bio — Bringing innovative therapies to patients

Companies similar to Draupnir Bio

Tacalyx GmbH logo — alternative to Draupnir Bio

Tacalyx GmbH

Tacalyx develops the next generation of anti-Cancer therapeutics in indications with high...

Opsona Therapeutics logo — alternative to Draupnir Bio
iN Therapeutics logo — alternative to Draupnir Bio

iN Therapeutics

의학 및 약학 연구개발업

AN2 Therapeutics logo — alternative to Draupnir Bio

AN2 Therapeutics

Developing therapies for rare, chronic, and serious infectious diseases

Rival Readout

Competing with Draupnir Bio? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Ousia Pharma logo — alternative to Draupnir Bio

Ousia Pharma

Danish biotech company developing peptide-small molecule drugs for treatment of obesity

Amyl Therapeutics logo — alternative to Draupnir Bio

Amyl Therapeutics

Restoring clarity in amyloid diseases

Pharmasset, Inc. logo — alternative to Draupnir Bio
SPARTA Biodiscovery logo — alternative to Draupnir Bio

SPARTA Biodiscovery

Enabling nanoformulations for next-generation therapeutics

PineTree Therapeutics Inc logo — alternative to Draupnir Bio

PineTree Therapeutics Inc

Disruptive Innovations to Treat Unmet Therapeutic Needs in Oncology

Benitec Biopharma Inc. logo — alternative to Draupnir Bio

Benitec Biopharma Inc.

Silencing genes for life

Covagen AG logo — alternative to Draupnir Bio

Covagen AG

Crafting next-generation therapies through innovative protein and antibody fusion for enha...

Intract Pharma logo — alternative to Draupnir Bio

Intract Pharma

Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics...

About Draupnir Bio

Draupnir Bio is a Danish biotechnology company founded in 2017 with the slogan "Bringing innovative therapies to patients." The company is focused on developing oral, small molecule degraders of extracellular pathogenic proteins, which is a pioneering approach in the field of targeted protein degradation (TPD). This ap...

Business keywords

Therapeutics, Innovation, Cholesterol-lowering, Cardiovascular, Glycome Exploration, Array Technology, Protein Chemistry, Carbohydrate Chemistry, Heparan Sulfate, Drug Development, Infectious Diseases, Research, Spin-out, Max-Planck Society

Frequently Asked Questions

Companies similar to Draupnir Bio include Tacalyx GmbH, Opsona Therapeutics, iN Therapeutics, AN2 Therapeutics, Ousia Pharma. They work in Biotechnology and Health and Wellness and share Draupnir Bio's focus on drug development, therapeutics and infectious diseases.
Bounce Watch lists 12 companies that share Draupnir Bio's industries and are closest to it in business tags, services, target customers, business model and size.
Draupnir Bio is a Danish biotechnology company founded in 2017 with the slogan "Bringing innovative therapies to patients." The company is focused on developing oral, small molecule degraders of extracellular pathogenic proteins, which is a pioneering approach in the field of targeted protein degradation (TPD). This ap...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Draupnir Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Draupnir Bio on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout